ArticleESMO real world data and digital oncology2024

Real-world safety and effectiveness of neoadjuvant chemotherapy combination with pembrolizumab in triple-negative breast cancer.

L Rached et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.